The thoracic surgery devices market size is expected to see strong growth in the next few years. It will grow to $14.34 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising demand for advanced instrument sets tailored to complex chest surgeries, increasing adoption of ergonomic and surgeon-friendly device designs, expansion of ambulatory thoracic surgery capabilities in select procedures, growing procedural volumes driven by aging population and chronic respiratory conditions, stronger focus on patient outcome improvement and post-operative recovery optimization. Major trends in the forecast period include increasing utilization of specialized thoracic forceps graspers clamps staplers and spreaders to support complex chest and lung surgeries, growing adoption of precision surgical instruments to enhance visualization control and accuracy during thoracic procedures, rising procedural volumes in lobectomy wedge resection and pneumonectomy driving demand for multi-functional instrument sets, expansion of thoracic surgery capability across hospitals and ambulatory surgical centers to improve patient access and outcomes, increasing preference for ergonomically designed needle holders scissors and retraction devices to support surgeon efficiency.
The rising prevalence of thoracic diseases is expected to drive the growth of the thoracic surgery device market going forward. Thoracic diseases include a wide range of conditions affecting the organs and structures within the thoracic cavity, such as the heart, lungs, esophagus, trachea, diaphragm, and major blood vessels. Thoracic surgery devices assist surgeons in performing procedures within the chest cavity, ensuring precision, efficacy, and patient safety. For example, in June 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic obstructive pulmonary disease (COPD) accounted for 3.6% of the total disease burden and represented 50% of the total respiratory disease burden in 2023. Therefore, the increasing prevalence of thoracic diseases is fueling the growth of the thoracic surgery device market.
Companies in the thoracic surgery device market are focusing on developing advanced plate and screw fixation systems to enhance post-surgical outcomes. One such innovation is the rigid internal sternal fixation system, a surgical device designed to stabilize and support the sternum using plates and screws, ensuring proper alignment and promoting bone healing after sternotomy or other thoracic procedures. For instance, in August 2024, DePuy Synthes, a US-based medical device company, launched the MatrixSTERNUM fixation system. This plate and screw system stabilizes the chest wall following open-heart and thoracic surgeries. It offers superior locking strength - three times greater than the leading competitor - enabling better sternum fixation during recovery. Its multi-hole screw guides allow rapid and accurate plate placement, reducing procedure time, while the 1.5 mm low-profile plates are thin, contourable, and minimally visible under the skin, improving patient comfort and surgical outcomes.
In August 2024, Getinge AB, a Sweden-based medical technology company, acquired Paragonix Technologies for approximately US$477 million. This acquisition aims to enhance Getinge’s organ preservation and transplant logistics capabilities by integrating Paragonix’s advanced organ transport and storage systems, thereby improving reliability and outcomes for heart and lung transplants. Paragonix Technologies is a US-based company specializing in organ preservation and transport solutions for cardiac and thoracic transplantation.
Major companies operating in the thoracic surgery devices market are Medtronic plc, Danaher Corporation, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical, Getinge AB, Teleflex Inc., Richard Wolf GmbH, Scanlan International, OmniGuide Holdings Inc., KLS Martin Group, Sklar Surgical Instruments, Dextera Surgical Inc., Biolitec AG, Johnson & Johnson, Cardio medical GmbH, LivaNova plc, Sinapi Biomedical, Medacta International SA, Aesculap AG, Medline Industries Inc.
North America was the largest region in the thoracic surgery devices market in 2025. The regions covered in the thoracic surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the thoracic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are affecting the thoracic surgery devices market by increasing costs for metal alloys, precision-engineered components, and finished surgical instruments such as forceps, graspers, clamps, staplers, spreaders, and needle holders that are commonly sourced through global supply chains, leading to higher procurement prices for hospitals and surgical centers. Regions with substantial import dependence across Europe, North America, and parts of Asia-Pacific are experiencing pricing pressure and longer sourcing cycles, particularly for premium and specialty thoracic instrument sets. However, tariffs have also encouraged localized production, regional sterilization and assembly operations, and supplier diversification, supporting domestic manufacturers and creating selective cost and availability advantages in certain markets.
The thoracic surgery devices market research report is one of a series of new reports that provides thoracic surgery devices market statistics, including thoracic surgery devices industry global market size, regional shares, competitors with a thoracic surgery devices market share, detailed thoracic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the thoracic surgery devices industry. This thoracic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Thoracic surgery devices encompass a diverse array of specialized instruments and equipment crafted for utilization in surgeries concerning the thorax, the region that encompasses vital structures such as the lungs, heart, and esophagus within the chest area. These devices are meticulously designed to afford surgeons precise control and enhanced visualization during surgical interventions, thereby minimizing the risk of complications and elevating overall patient outcomes.
The primary product categories within thoracic surgery devices include forceps, graspers, clamps and staplers, scissors, spreaders, needle holders, and various other instruments. Forceps, characterized as handheld and hinged tools, find application in medical and surgical procedures, serving functions such as grasping, holding, and applying traction, particularly in delicate surgical contexts. Diverse surgery types, including lobectomy, wedge resection, pneumonectomy, and others, make use of these devices, with end-users spanning hospitals, ambulatory surgical centers, and other medical settings.
The thoracic surgery devices market includes revenues earned by entities by providing products such as thoracoscope, thoracic drainage systems, thoracic retractors and tissue sampling devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Thoracic Surgery Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses thoracic surgery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for thoracic surgery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The thoracic surgery devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Forceps; Graspers; Clamps And Staplers; Scissors; Spreaders; Needle Holders; Other Products2) By Surgery Type: Lobectomy; Wedge Resection; Pneumonectomy; Other Surgery Types
3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Forceps: Straight Forceps; Curved Forceps2) By Graspers: Tissue Graspers; Vessel Graspers
3) By Clamps and Staplers: Surgical Clamps; Stapling Devices
4) By Scissors: Surgical Scissors; Dissecting Scissors
5) By Spreaders: Rib Spreaders; Tissue Spreaders
6) By Needle Holders: Standard Needle Holders; Fine Tip Needle Holders
7) By Other Products: Electrosurgical Instruments; Surgical Retractors
Companies Mentioned: Medtronic plc; Danaher Corporation; Stryker Corporation; B. Braun Melsungen AG; Olympus Corporation; Intuitive Surgical; Getinge AB; Teleflex Inc.; Richard Wolf GmbH; Scanlan International; OmniGuide Holdings Inc.; KLS Martin Group; Sklar Surgical Instruments; Dextera Surgical Inc.; Biolitec AG; Johnson & Johnson; Cardio medical GmbH; LivaNova plc; Sinapi Biomedical; Medacta International SA; Aesculap AG; Medline Industries Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Thoracic Surgery Devices market report include:- Medtronic plc
- Danaher Corporation
- Stryker Corporation
- B. Braun Melsungen AG
- Olympus Corporation
- Intuitive Surgical
- Getinge AB
- Teleflex Inc.
- Richard Wolf GmbH
- Scanlan International
- OmniGuide Holdings Inc.
- KLS Martin Group
- Sklar Surgical Instruments
- Dextera Surgical Inc.
- Biolitec AG
- Johnson & Johnson
- Cardio medical GmbH
- LivaNova plc
- Sinapi Biomedical
- Medacta International SA
- Aesculap AG
- Medline Industries Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.47 Billion |
| Forecasted Market Value ( USD | $ 14.34 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |


